Meyer Andrew Hollman 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Meyer Andrew Hollman（CIK 1864159）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-01-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-01-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 1,879 | $25,799 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 3,333 | $35,296 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 2,700 | $88,695 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 633 | $21,218 |
| 2025-11-14 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 3,333 | $35,296 |
| 2025-11-14 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 3,333 | $99,990 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 9,999 | $42,096 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 6,666 | $70,593 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 16,665 | $500,950 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 3,333 | $14,032 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 2,933 | $93,709 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 400 | $13,040 |
| 2025-04-23 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 买入 | 3,334 | $14,036 |
| 2025-04-23 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | 卖出 | 3,334 | $100,020 |
来源：SEC Form 4 申报文件 · 截至 2026-01-02